Archimedes submits NasalFent NDA

Archimedes Pharma Ltd. (Reading, U.K.) said on Monday it submitted an NDA to FDA for NasalFent fentanyl nasal spray to treat breakthrough cancer pain. The application was submitted on Aug. 31 under se...